| Nicholas Seenath, PA-C | |
|
170 William St, New York, NY 10038-2612 | |
| (732) 421-0825 | |
| Not Available |
| Full Name | Nicholas Seenath |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 170 William St, New York, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124719448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 029958 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Seenath, PA-C 669 Montgomery St, Elizabeth, NJ 07202-3627 Ph: (732) 421-0825 | Nicholas Seenath, PA-C 170 William St, New York, NY 10038-2612 Ph: (732) 421-0825 |
News Archive
Under the EU Sixth Framework Programme (FP6) for Research and Development (2002-2006) 2.2 million Euros have been awarded to the 3DGENOME-research program.
DPS Health, a leader in digital behavior change interventions for emergent-risk populations, announced today the launch of its health self-management solution. Designed for health plans, providers systems and employers that are setting population health strategies for the emergent-risk population – adults with one or more pre-chronic or early-stage chronic conditions – the solution includes multi-channel consumer engagement to educate and enroll populations, Virtual Lifestyle ManagementTM to help individuals embrace healthy lifestyles, and a suite of condition-based, self-management programs to help the same individuals manage the impact of one or more conditions.
Drug-resistant infections are set to kill more people than cancer by 2050. Now a new University of Plymouth spinout company has been established to help tackle the problem - by developing new antibiotics and bringing them to market.
Researchers from the University of Tsukuba identify a novel mechanism by which the protein CREB3L3 protects against atherosclerosis.
Chronic narcotic use is more than twice as prevalent in children with inflammatory bowel disease (IBD), compared with children without this disease, according to a new study1 published in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.
› Verified 4 days ago
Dr. Ravishankar Ramaswamy, MD, MS Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737 | |
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692 | |
Dr. Rakhshan Mahmood Chida, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690 | |
Charles D Resor, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913 | |
Dr. Jacqueline Yuey Lonier, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494 | |
Dr. Sharon Uralil, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-3293 | |
Diana Kantor, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550 |